Investment ThemesDetailed Quotes
Weight Loss Drugs
Watchlist
GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
- 1725.808
- -21.674-1.24%
Close Oct 31 16:00 ET
1749.423High1712.247Low
1722.656Open1747.482Pre Close62.23MVolume3Rise62.54P/E (Static)8.73BTurnover--Flatline0.59%Turnover Ratio1.63TMarket Cap4Fall1.49TFloat Cap
Constituent Stocks: 7Top Rising: GPCR+8.69%
Eli Lilly lowered guidance on lackluster sales of its blockbuster weight-loss drug Zepbound and diabetes drug Mounjaro.
(watch this Bloomberg video - Gameover!)
*********
Let me say this. If LLY stock was to go up, you might get a maximum of $200 in the next 3 months. If it drops, it's going under $500. Remember this is all my opinion, do you own research. Just look at the chart. Also, if you see so many analysts trying to pump the stock, ...
The U.S. stock market is witnessing a revival of the "Trump Trade." Shares in Trump's social media venture, $Trump Media & Technology (DJT.US)$, have soared more than 220% since Octobe...
The chart has been damaged. Don't expect a move back up without a complete test of support at 746.50. if that breaks, watch out it's a long way down. There is a hole in the ship right now, and everyone is in denial until it's too late.
No comment yet